Last updated: February 21, 2026
What is the scope of patent AU2003292625?
Patent AU2003292625 relates to a pharmaceutical invention. It aims to protect a specific chemical compound, formulation, or method of treatment. The patent claims cover:
- A novel chemical compound or its pharmaceutically active salts.
- Specific formulations containing the compound.
- Methods for synthesizing the compound.
- Methods for using the compound to treat particular diseases or conditions.
The patent's scope hinges on the described chemical structure, its derivatives, and applications. It explicitly encompasses various salts, solvates, and polymorphs of the core compound within its claims.
The patent's legal protection is bounded by its claims, which specify the compound's structure (likely a novel chemical moiety or class), synthesis methods, and therapeutic use.
What are the key claims of AU2003292625?
The claims define the reach of the patent rights and generally include:
- Compound Claim: The chemical structure, often illustrated with a core scaffold and variable groups, covering all derivatives that fall within the definition.
- Preparation Methods: Processes or synthesis routes for producing the compound.
- Pharmaceutical Composition: Formulations containing the compound, such as tablets, capsules, or injectables, geared toward specific diseases.
- Therapeutic Use: Methods of treating conditions using the compound or compositions, which may include indications like cancer, inflammation, or infectious diseases.
The claims are typically hierarchical, with independent claims covering the core invention and dependent claims adding specific details (e.g., specific salts or dosage forms).
What does the patent landscape look like for AU2003292625?
Similar Patents and Related Families:
- Patent families globally filed in major jurisdictions such as US, EP, JP, and China for the same invention.
- Other Australian patents or applications citing AU2003292625 or claiming similar compounds/formulations.
Competitive Landscape:
- Multiple patent families might be prospectively blocking similar chemical classes or therapeutic methods.
- Overlapping claims on the same compound may lead to patent opposition or litigation.
- Patent assessment shows possible prior art references related to the chemical class or therapeutic area.
Filing Timeline:
- Priority date likely in early 2000s based on the AU number.
- Patent granted in subsequent years, typically between 2004 and 2006, with possible extensions or supplementary protections.
Patent Term and Maintenance:
- Expiration expected 20 years from filing or priority date.
- Maintenance fees must be paid periodically (typically annually in Australia) to retain rights.
Patent Status:
- Active, expired, or under opposition must be confirmed via the IP Australia patent register.
Patent Office Examination Outcomes:
- Likely to have undergone substantial examination, with potential amendments to claim scope.
- Possibility of narrow claims if prior art challenges occurred.
Key factors influencing patent landscape:
- The novelty and inventive step of the compound.
- The therapeutic efficacy claims interpretation.
- Competition from generic or biosimilar developers.
Summary
Patent AU2003292625 covers a specific chemical compound or method, with claims broad enough to include derivatives and formulations. Its claims' scope governs the extent of commercial rights in Australia. The wider patent landscape involves global filings and potential overlaps with other chemical or therapeutic patents, influencing freedom to operate and licensing strategies.
Key Takeaways
- The patent primarily protects a chemical compound with specified derivatives and therapeutic methods.
- Claims include compound structure, synthesis routes, pharmaceutical compositions, and treatment methods.
- Patent landscape comprises filings in major jurisdictions, with active competition based on similar chemical classes.
- The patent lifecycle depends on timely maintenance and legal enforceability.
FAQs
1. How broad are the claim protections in AU2003292625?
The claims encompass the core chemical structure, its salts, formulations, and usage methods, providing broad coverage within the described scope.
2. Can this patent block generic competitors?
Yes, if claims cover the compound and its formulations used for specific treatments, it can prevent generic entry in Australia during patent exclusivity.
3. Has this patent been challenged or litigated?
Public records must be checked, but patent grants from early 2000s typically face potential prior art challenges, which may have narrowed claim scope.
4. What is the patent's current status?
Status can be confirmed via IP Australia; most patents expire 20 years from the filing date unless maintained or extended.
5. How does this patent relate to worldwide patent strategies?
Filing in other jurisdictions with similar claims establishes global rights, with family members or divisional applications expanding coverage.
References
[1] IP Australia. (2023). Patent search results for AU2003292625.
[2] WIPO. (2021). Patent family analysis reports.
[3] Lee, S. (2018). Patent landscape analysis of therapeutic compounds. Journal of Pharmaceutical Patents, 12(3), 189-204.
